<?xml version="1.0" encoding="UTF-8"?>
<p>The use of non-parenteral routes of administration of dsRNA as an adjuvant is particular interesting. For example, mucosal treatment with PolyI: PolyC shortly after vaccination of mice with live attenuated influenza vaccines enhanced the functional activity of the respiratory tract DC, formation of CD8+ T-cells and production of neutralizing antibodies [
 <xref ref-type="bibr" rid="CR105">105</xref>].
</p>
